RYDER. (DILLARD) New Act Creates the Patient Access to Treatment Act. Provides that managed care entities may not deny or limit reimbursement to a member for dermatological services on the grounds that the member was not referred to the provider by a person acting on behalf of the managed care entity. Prohibits unreasonable cost-sharing arrangements. Requires terms and conditions of coverage to be disclosed in a readable and understandable format consistent with standards developed for supplemental insurance coverage under the federal Social Security Act. Effective immediately. 99-02-22 H FIRST READING 99-02-22 H REFERRED TO HOUSE RULES COMMITTEE RULES 99-02-24 H ASSIGNED TO COMMITTEE HEALTH CARE 99-03-03 H DO PASS/SHORT DEBATE 014-000-003 HCAA 99-03-03 H PLACED CALENDAR 2ND READING-SHORT DEBATE 99-03-16 H SECOND READING-SHORT DEBATE 99-03-16 H PLCD CAL ORDER 3RD READING-SHORT DEBATE 99-03-18 H THIRD READING/SHORT DEBATE/PASSED 103-011-001 99-03-19 S ARRIVE IN SENATE 99-03-19 S PLACED CALENDAR ORDER OF FIRST READING 99-03-22 99-03-24 S CHIEF SPONSOR DILLARD 99-03-24 S FIRST READING 99-03-24 S REFERRED TO SENATE RULES COMMITTEE RULES 01-01-09 H SESSION SINE DIE END OF INQUIRY Full Text Bill Summary